S. Sena

Statistics

Publications

Citations

2.9K

H-Index

Active since

1999

Affiliations

Budgetary Health Care Institution of the Omsk Region "Clinical Oncology Center"(Current)

AstraZeneca (United States)

Hospital El Cruce

Hospital Universitario 12 De Octubre

Institute of Oncology NN Petrov

S. Sena is an author at Budgetary Health Care Institution of the Omsk Region "Clinical Oncology Center" specializing in oncology, lung cancer pharmacotherapy, and cancer pharmacology.

ORCID

Publications per year

1999–2020

Publications

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Luis Paz‐Ares, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet · 2019 · 2.2K citations

Medicine, Oncology, Pharmacology +14

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

Jonathan W. Goldman, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet Oncology · 2020 · 687 citations · Full text

Medicine, Oncology, Pharmacology +14

Single-agent gemcitabine in pretreated patients with non-small-cell lung cancer: results of an Argentinean multicentre phase II trial

Maximiliano Van Kooten, G. Traine, Gabriela Cinat et al. · British Journal of Cancer · 1999 · 23 citations · Full text

Medicine, Oncology, Pharmacology +14

Efficacy and Safety of Nivolumab in Previously Treated Patients With Non–Small-cell Lung Cancer: Real World Experience in Argentina

Claudio Martín, Lorena Lupinacci, Florencia Perazzo et al. · Clinical Lung Cancer · 2020 · 23 citations

Pharmacy, Oncology, Pharmacotherapy +8

1–4 of 4